BRIEF published on 04/10/2025 at 07:05, 1 year 1 month ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
BRIEF published on 04/10/2025 at 07:05, 1 year 1 month ago Relief Therapeutics annonce ses résultats financiers et ses progrès stratégiques pour 2024 Biopharmaceutique Maladies Rares THÉRAPEUTIQUE DE SECOURS Résultats Financiers 2024 Progrès Du Pipeline
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year 1 month ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 year 2 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
BRIEF published on 03/06/2025 at 07:05, 1 year 2 months ago Relief Therapeutics met fin aux discussions de fusion avec Renexxion Valeur Actionnariale Objectifs Stratégiques THÉRAPEUTIQUE DE SECOURS Renexxion Fin De La Fusion
PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 2 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
BRIEF published on 02/11/2025 at 07:05, 1 year 3 months ago European Patent Office Grants Relief Therapeutics Patent for RLF-TD011 Biopharmaceuticals Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
BRIEF published on 02/11/2025 at 07:05, 1 year 3 months ago L'Office européen des brevets accorde un brevet thérapeutique de secours pour le RLF-TD011 Produits Biopharmaceutiques THÉRAPEUTIQUE DE SECOURS RLF-TD011 Brevet Européen Epidermolyse Bulleuse
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 3 months ago Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
BRIEF published on 01/22/2025 at 07:05, 1 year 3 months ago Relief Therapeutics Sells GOLIKE Rights, Shifts Focus to R&D Relief Therapeutics GOLIKE Sale Nutrisens Partnership Biopharmaceutical Strategy R&D Focus
Published on 05/11/2026 at 23:00, 55 minutes ago Revolve to Present at the 16th Annual LD Micro Invitational on May 18, 2026
Published on 05/11/2026 at 19:55, 4 hours ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 4 hours 25 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 9 hours 25 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 9 hours 55 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 22:05, 1 hour 50 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 1 hour 50 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 2 hours 39 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 3 hours 12 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 3 hours 15 minutes ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:02, 4 hours 53 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 5 hours 37 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 5 hours 37 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 5 hours 40 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 5 hours 40 minutes ago Number of shares and voting rights - April 2026 (In French only)
